| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
IOvations is a Burlington, MA-based company in the Software and Internet sector.
Amazon is a company that aims to be Earths most customer-centric company. They provide a wide range of products and services, including e-commerce, publishing, development platforms, and consumer electronic devices. Their headquarters are in Seattle, ...
TechScholar helps B2B sales and marketing managers increase sales with effective, timely and consistent Product Sales Training delivered to geographically dispersed sales teams.
Changing the way people live, work and play.